Apyx Medical (APYX) Liabilities from Discontinued Operations (2017)

Apyx Medical (APYX) reported Liabilities from Discontinued Operations of 2248000.0 for Q4 2017.

Apyx Medical (APYX) Liabilities from Discontinued Operations (2017) Analysis & Trends

Apyx Medical has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 2248000.0 in Q4 2017.

  • For the quarter ending Q4 2017, Liabilities from Discontinued Operations changed N/A year-over-year to 2248000.0; the trailing twelve-month figure through Dec 2017 stood at 2248000.0 (changed N/A YoY), and the FY2017 full-year result was 2248000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations for Q4 2017 stood at 2248000.0.
  • The five-year high for Liabilities from Discontinued Operations was 2248000.0 in Q4 2017, with the low at 2248000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Apyx Medical 205.37 Mn 174.49 Mn 7.93 Mn

Historic Data

Download Data
DateValue
Dec 31, 2017 2.25 Mn
Dec 31, 2017 2.25 Mn